O	0	1	A
O	2	8	single
O	8	9	-
O	9	16	session
B-intervention	17	27	acceptance
I-intervention	28	31	and
I-intervention	32	42	commitment
I-intervention	43	50	therapy
O	51	63	intervention
O	64	69	among
B-eligibility	70	75	women
I-eligibility	76	86	undergoing
I-eligibility	87	94	surgery
I-eligibility	95	98	for
I-eligibility	99	105	breast
I-eligibility	106	112	cancer
O	112	113	:
O	114	115	A
O	116	126	randomized
O	127	132	pilot
O	133	138	trial
O	139	141	to
O	142	148	reduce
O	149	159	persistent
B-condition	160	172	postsurgical
I-condition	173	177	pain
O	177	178	.

O	179	188	Oncologic
O	189	195	breast
O	196	205	surgeries
O	206	211	carry
O	212	213	a
O	214	218	risk
O	219	222	for
O	223	233	persistent
O	234	246	postsurgical
O	247	251	pain
O	251	252	.

O	253	257	This
O	258	263	study
O	264	267	was
O	268	269	a
O	270	280	randomized
O	281	286	pilot
O	287	290	and
O	291	302	feasibility
O	303	308	study
O	309	311	of
O	312	313	a
O	314	320	single
O	320	321	-
O	321	328	session
O	329	339	Acceptance
O	340	343	and
O	344	354	Commitment
O	355	362	Therapy
O	363	364	(
O	364	367	ACT
O	367	368	)
O	369	381	intervention
O	382	390	compared
O	391	395	with
O	396	405	treatment
O	406	408	as
O	409	414	usual
O	415	420	among
B-eligibility	421	426	women
I-eligibility	427	437	undergoing
I-eligibility	438	445	surgery
I-eligibility	446	449	for
I-eligibility	450	456	breast
I-eligibility	457	463	cancer
I-eligibility	464	466	or
I-eligibility	467	473	ductal
I-eligibility	474	483	carcinoma
I-eligibility	484	486	in
I-eligibility	487	491	situ
O	491	492	.

O	493	505	Participants
O	506	510	were
O	511	520	recruited
O	521	524	via
O	525	531	letter
O	532	534	of
O	535	545	invitation
O	546	549	and
O	550	556	follow
O	556	557	-
O	557	559	up
O	560	565	phone
O	566	570	call
O	571	575	from
O	576	577	a
O	578	584	single
O	585	589	site
O	590	592	in
O	593	596	the
B-location	597	603	United
I-location	604	610	States
O	611	615	from
O	616	620	2015
O	621	623	to
O	624	628	2017
O	628	629	.

O	630	642	Participants
O	643	647	were
O	648	650	at
O	651	655	risk
O	656	659	for
O	660	670	persistent
O	671	683	postsurgical
O	684	688	pain
O	688	689	,
O	690	695	based
O	696	698	on
O	699	704	young
O	705	708	age
O	709	710	(
O	710	711	<
O	711	713	50
O	713	714	)
O	714	715	,
O	716	717	a
O	718	729	preexisting
O	730	737	chronic
O	738	742	pain
O	743	752	condition
O	752	753	,
O	754	756	or
O	757	765	elevated
O	766	773	anxiety
O	773	774	,
O	775	785	depression
O	785	786	,
O	787	789	or
O	790	794	pain
O	795	810	catastrophizing
O	810	811	.

O	812	815	The
B-total-participants	816	818	54
O	819	831	participants
O	832	836	were
O	837	843	female
O	844	848	with
O	849	850	a
O	851	855	mean
O	856	859	age
O	860	862	of
B-age	863	865	52
I-age	865	866	.
I-age	866	868	91
I-age	869	874	years
O	875	876	(
O	876	878	SD
O	878	879	=
O	879	881	11
O	881	882	.
O	882	884	80
O	884	885	)
O	885	886	.

O	887	889	At
O	890	891	3
O	891	892	-
O	892	897	month
O	898	909	postsurgery
O	909	910	,
O	911	913	11
O	913	914	%
O	915	917	of
O	918	921	the
O	922	928	sample
O	929	937	reported
B-outcome	938	946	moderate
I-outcome	946	947	-
I-outcome	947	953	severe
I-outcome	954	958	pain
O	959	960	(
O	960	961	>
O	961	962	3
O	963	965	on
O	966	967	a
O	968	969	0
O	969	970	-
O	970	972	10
O	973	980	numeric
O	981	987	rating
O	988	993	scale
O	993	994	)
O	995	997	in
O	998	1001	the
O	1002	1011	operative
O	1012	1018	breast
O	1019	1021	or
O	1022	1026	with
O	1027	1030	arm
O	1031	1039	movement
O	1039	1040	.

O	1041	1048	Written
O	1049	1060	qualitative
O	1061	1070	responses
O	1071	1080	indicated
O	1081	1085	that
O	1086	1089	the
O	1090	1098	majority
O	1099	1101	of
O	1102	1114	participants
O	1115	1118	who
O	1119	1127	received
O	1128	1131	the
O	1132	1144	intervention
O	1145	1155	understood
O	1156	1159	the
O	1160	1168	concepts
O	1169	1178	presented
O	1179	1182	and
O	1183	1191	reported
O	1192	1201	continued
O	1202	1210	practice
O	1211	1213	of
O	1214	1223	exercises
O	1224	1231	learned
O	1232	1234	in
O	1235	1238	the
O	1239	1246	session
O	1246	1247	.

O	1248	1251	The
O	1252	1259	between
O	1260	1265	group
O	1266	1272	effect
O	1273	1278	sizes
O	1279	1282	for
B-outcome	1283	1291	moderate
I-outcome	1291	1292	-
I-outcome	1292	1298	severe
I-outcome	1299	1303	pain
I-outcome	1304	1307	and
I-outcome	1308	1316	elevated
I-outcome	1317	1324	anxiety
I-outcome	1325	1327	at
I-outcome	1328	1329	3
I-outcome	1329	1330	-
I-outcome	1330	1335	month
I-outcome	1336	1340	post
I-outcome	1340	1341	-
I-outcome	1341	1348	surgery
O	1349	1353	were
O	1354	1359	small
O	1360	1361	(
O	1361	1364	Phi
O	1364	1365	=
O	1365	1366	0
O	1366	1367	.
O	1367	1369	08
O	1370	1373	and
O	1374	1375	0
O	1375	1376	.
O	1376	1378	16
O	1378	1379	,
O	1380	1392	respectively
O	1392	1393	)
O	1393	1394	.

O	1395	1398	The
O	1399	1406	between
O	1407	1412	group
O	1413	1419	effect
O	1420	1425	sizes
O	1426	1429	for
B-outcome	1430	1440	depression
I-outcome	1440	1441	,
I-outcome	1442	1446	pain
I-outcome	1447	1457	acceptance
I-outcome	1457	1458	,
I-outcome	1459	1462	and
I-outcome	1463	1467	pain
O	1468	1483	catastrophizing
O	1484	1486	at
O	1487	1488	3
O	1488	1489	-
O	1489	1494	month
O	1495	1506	postsurgery
O	1507	1511	were
O	1512	1519	minimal
O	1519	1520	.

O	1521	1525	This
O	1526	1531	study
O	1532	1537	found
O	1538	1543	small
O	1544	1552	positive
O	1553	1560	effects
O	1561	1563	on
B-outcome	1564	1576	postsurgical
I-outcome	1577	1581	pain
I-outcome	1582	1585	and
I-outcome	1586	1593	anxiety
O	1594	1597	for
O	1598	1599	a
O	1600	1606	single
O	1606	1607	-
O	1607	1614	session
O	1615	1618	ACT
O	1619	1631	intervention
O	1632	1637	among
O	1638	1643	women
O	1644	1648	with
O	1649	1655	breast
O	1656	1662	cancer
O	1662	1663	.

O	1664	1668	This
O	1669	1674	study
O	1675	1683	supports
O	1684	1687	the
O	1688	1691	use
O	1692	1694	of
O	1695	1698	ACT
O	1699	1703	with
O	1704	1708	this
O	1709	1719	population
O	1719	1720	.
